Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 718-723

  Feilotter, H E ^a   Coulon, V ^b   McVeigh, J L ^a   Boag, A H ^a   Dorion Bonnet, F ^b   Duboue B ^b   Latham, W C W ^a   Eng, C ^c   Mulligan, L M ^a   Longy, M ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b INSTITUT BERGONIÉ   (France)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Breast carcinoma; Chromosome 10q; Cowden disease; PTEN

Indexed keywords

ALLELE; ARTICLE; BREAST CARCINOMA; CHROMOSOME 10Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; COWDEN SYNDROME; DENATURING GRADIENT GEL ELECTROPHORESIS; GENE DELETION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CENTROMERE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0033003079     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690115     Document Type: Article

References (63)

1. Albarosa R, Colombo BM, Roz L, Magnani I, Pollo B, Cirenei N, Giani C, Conti AMF, DiDonato S and Finocchiaro G (1996) Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet 58: 1260-1267
2. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS (1989) Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190
3. Bieché I and Lidereau R (1995) Genetic alterations in breast cancer. Genes Chrom Cancer 14: 227-251
4. Bostrom J, Cobbers JMJL, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP and Reifenberger G (1998) Mutation of the PTEN (MMACI) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 58: 29-33
5. Brownstein MH, Wolf M and Bikowski JB (1978) Cowden's disease: a cutaneous marker of breast cancer. Cancer 41: 2393-2398
6. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS and Sidransky D (1997) Frequent inactivation of PTEN/MMACI in primary prostate cancer. Cancer Res 57: 4997-5000
7. Chen J, Lindblom P and Lindblom A (1998) A study of the PTEN/MMACI gene in 136 breast cancer families. Hum Genet 102: 124-125
8. Chumakov IM, Rigault P, Le Gall I, Bellanne-Chantelot C, Billault A, Guillou S, Soularue P, Guasconi G, Poullier E, Gros I, Belova M, Sambucy J, Susini L, Gervy P, Glibert F, Beaufils S, Bui H, Massart C, De Tand M, Dukasz F, Lecoulant S, Ougen P, Perrot V, Saumier M, Soravito C, Bahouayila R, Cogen-Akenine A, Barillot E, Bertrand S, Codani J, Caterina D, Georges I, Lacroix B, Lucotte G, Sahbatou M, Schmit C, Sangouard M, Tubacher E, Dib C, Faure S, Fizames C, Gyapay G, Millasseau P, Nguyen S, Muselet D, Vignal A, Morissette J, Menninger J, Lieman J, Desai T, Banks A, Bray-Ward P, Ward D, Hudson T, Gerety S, Foote S, Stein L, Page DC, Lander ES, Weissenbach J, Le Paslier D and Cohen D (1995) A YAC contig map of the human genome. Nature 377: 175-297
9. Devilee P and Cornelisse CJ (1994) Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113-130
10. Dorion-Bonnet F, Mautalen S, Hostein I and Longy M (1995) Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer 14: 171-181
11. Feilotter HE, Nagai MA, Boag AH, Eng C and Mulligan LM (1998) Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene 16: 1743-1748
12. FitzGerald MG, Marsh DJ, Wahrer D, Bell D, Caron S, Shannon KE, Ishioka C, Isselbacher KJ, Garber JE, Eng C and Haber DA (1998) Germline mutations in PTEN, are an infrequent cause of genetic predisposition to breast cancer. Oncogene 17: 727-731
13. Fujii H, Szumel R, Marsh C, Zhou W and Gabrielson E (1996) Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 56: 5260-5265
14. Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weissenbach J and Spurr NK (1996) Loss of the chromosomal region 10q23-25 in prostate cancer, Cancer Res 55: 4800-4803
15. Gray IC, Fallowfield J, Ford S, Nobile C, Volpi EV and Spurr NK (1997) An integrated physical and genetic map spanning chromosome hand 10q24. Genomics 43: 85-88
16. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J (1997) Disruption of the MMACI/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663
17. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Benardi G, Lathrop M and Weissenbach J (1994) The 1993-94 Genethon human genetic linkage map. Nature Genet 7: 246-339
18. Herbst RA, Weiss J, Ehnis A, Cavenee WK and Arden KC (1994) Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res 54: 3111-3114
19. Ittmann M (1996) Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 56: 2143-2147
20. Kagan J, Liu J, Stein JD, Wagner SS, Babkowski R, Grossman BH and Katz RL (1998) Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer. Oncogene 16: 909-913
21. Karlbom AE, James CD, Boethius J, Cavenee WK, Collins VP, Nordenskjöld M and Larsson C (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92: 169-174
22. Kelsey J (1979) A review of the epidemiology of human breast cancer. Epidemiol Rev 1: 74-109
23. Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquenier J, Longy M, Sobol H and Birnbaum D (1996) Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCAI gene regions. Oncogene 13: 339-347
24. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A (1997) PTENI is frequently mutated in primary endometrial carcinomas. Nature Genet 17: 143-144
25. Laugé A, Lefebvre C, Laurent-Puig P, Gad S, Eng C, Longy M & Stoppa-Lyonnet D (1998) No evidence for germline PTEN mutations in families with breast and brain tumours. Int J Cancer (submitted)
26. Li D-M and Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res 57: 2124-2129
27. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947
28. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet 16: 64-67
29. Longy M, Coulon V, Duboué B, David A, Lurrègue M, Eng C, Amati P, Kraimps J-L, Bottani A, Lacombe D and Bonneau D (1998) Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype. J Med Genet (in press)
30. Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, Macleod PM, Kvinnsland S, Gjertsen BT, Heimdal K, Lubs H, Moller P and King M-C (1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am J Hum Genet 61: 1254-1260
31. Marsh DJ, Zheng Z, Zedenius J, Kremer H, Pudberg GW, Larsson C, Longy M and Eng C (1997). Differential loss of heterozygosity in the region of the Cowden locus wilhin 10q22-23 in lollicular thyroid adenomas and carcinomas. Cancer Res 57: 500-503
32. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Duhia PLM, Zheng Z, Liaw D, Caron S, Duboue B, Lin AY, Richardson A-L, Bonnetblanc J-M, Bressieux J-M, Cabarrot-Moreau A, Choumpret A, Demange L. Eeles RA, Yahanda AM, Fearon ER, Fricker J-P, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, LePrat F, Odent S, Toulouse C, Olopade OI, Sobol H, Tishler S, Woods CG, Robinson BG, Weber HC, Parsons R, Peacocke M, Longy M and Eng C (1998a) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7: 507-515
33. Marsh DJ, Dahia PLM, Coulon V, Zheng Z, Dorion-Bonnet F, Call KM, Little R, Lin AY, Eeles RA, Goldstein AM, Hodgson SV, Richardson A-L, Robinson BG, Weber HC, Longy M and Eng C (1998b) Allelec imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cuncer 21: 61-69
34. Midulla C, Deiorio P, Valli C, Felici A, Serpiesi DE, Marzetti L, Nofrani I and Vecchione A (1996) nm23 and p53 expression: correlation with DNA ploidy and other pragmatic parameters in breast cancer. Oncol Rep 3: 957-961
35. Morita R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K and Nakamura Y (1991) Common regions of deletion on chromosomes 5q, 6q and 10q in renal cell carcinoma. Cancer Res 51: 5817-5820
36. Moschonas NK, Spurr NK and Mao J (1996) Report of the first international workshop on human chromosome 10 mapping 1995. Cytogenet Cell Genet 72: 99-112
37. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parson R and Tonks NK (1997) PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052-9057
38. Nagai MA, Yamamoto L, Salaorni S, Pacheco MM, Brentani MM, Barbosa EM, Brentani RR, Mazoyer S, Smith SA, Ponder BAJ and Mulligan LM (1994) Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer 11: 58-62
39. Nagai MA, Medeiros AC, Brentani MM, Brentani RR, Marques LA, Mazoyer S and Mulligan LM (1995) Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology 52: 448-453
40. Nelen MR, Padberg GW, Peeters EAJ, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MMM, Easton DF, Eeles RA, Hodgson S, Mulvihill JJ, Murday VA, Tucker MA, Mariman ECM, Starink TM, Ponder BAJ, Ropers HH, Kremer H, Longy M and Eng C (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nature Genet 13: 114-116
41. Nelen MR, van Staveren WCG, Peeters EAJ, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns J-P, Sijmons RH, Woods DG, Mariman ECM, Padberg GW and Kremer H (1997) Germline mutations in the PTEN/MMACI gene in patients with Cowden disease. Hum Mol Genet 6: 1383-1387
42. Paramiter AH, Balaban G, Clark WHJ and Nowell PC (1988) Possible involvement of the chromosome region 10q24-26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet 30: 313-317
43. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ and Goodfellow PJ (1995) Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55: 1922-1926
44. Pershouse MA, Stubblefield E, Hadi A, Killary AM, Yung WKA and Steek PA (1993) Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 53: 5043-5050
45. Rasheed BKA, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD and Bigner SH (1995) Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243-2246
46. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH (1997) PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187 4190
47. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J (1997) Mutation analysis of the putative tumor suppressor gene PTEN/MMACI in primary breast carcinomas. Cancer Res 57: 3657-3659
48. Risinger JI, Hayes AK, Berchuck A and Barrett JC (1997) PTENIMMACI mutations in endometrial cancers. Cancer Res 57: 4736-4738
49. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G and Nakamura Y (1990) Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184-7189
50. Simon D, Hener S, Satyaswaroop PG, Farber M and Noumoff JS (1990) Is chromosome 10 a primary chromosomal abnormality in endometrial adenocarcinomas? Cancer Genet Cytogenet 47: 155-162
51. Singh B, Ittmann MM and Krolewski JJ (1998) Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 21: 166-171
52. Smith SA and Ponder BAJ (1993) Predisposing genes in breast and ovarian cancer: an overview, Tumori 79: 291-296
53. Starink TM, van der Veen JPW, Arwert F, de Waal LP, de Lange GG, Gille JJP and Eriksson AW (1986) The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 29: 222-233
54. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV (1997) Identification of a candidate gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced tumours. Nature Genet 15: 356-362
55. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pagès S, Ithier G, Ligot L, Fourquet A, Salmon RJ, Clough KB, Pouillart P, Bonaïti-Pellié C and Thomas G (1997) BRCAI sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am J Hum Genet 60: 1021-1030
56. Stratton MR (1996) Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 5: 1515-1519
57. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB and Bova GS (1998) Interfocal heterogeneity of PTEN/MMACI gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58: 204-209
58. Tashiro H, Blazes MS, Wu, R, Cho KR, Bose S, Wang SI, Li J, Parsons R and Ellenson LH (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940
59. Tryhus TM, Burgess AC, Wojno KJ, Clover TW and Macoska JA (1996) Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res 56: 2263-2267
60. Tsou HC, Teng DH-F, Ping XL, Brancolini V, Davis T, Hu R, Xie XX, Gruener AC, Schrager CA, Christiano AM, Eng C, Steek P, Ott J, Tavtigian SV and Peacocke M (1997) The role of MMACI munitions in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCAI-negative cases. Am J Hum Genet 61: 1036-1043
61. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R (1997) Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186
62. Wright DK and Manos MM (1990) Sample preparation from paraffin-embedded tissues. In PCR Protocols: a Guide to Methods and Application, pp. 153-158. Academic Press: San Diego
63. Zedenius J, Wallin G, Svensson A, Bovée J, Höög A, Bäckahl M and Larsson C (1996) Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum Genet 97: 299-303